Increases in protein kinase C gamma immunoreactivity in the spinal cord of rats associated with tolerance to the analgesic effects of morphine

J Mao, DD Price, LL Phillips, J Lu, DJ Mayer - Brain research, 1995 - Elsevier
J Mao, DD Price, LL Phillips, J Lu, DJ Mayer
Brain research, 1995Elsevier
Our previous studies have indicated a critical role of protein kinase C (PKC) in intracellular
mechanisms of tolerance to morphine analgesia. In the present experiments, we examined
(1) the cellular distribution of a PKC isoform (PKCγ) in the spinal cord dorsal horn of rats
associated with morphine tolerance by utilizing an immunocytochemical method and (2) the
effects of the N-methyl-d-aspartate receptor antagonist MK-801 on tolerance-associated
PKCγ changes. In association with the development of tolerance to morphine analgesia …
Our previous studies have indicated a critical role of protein kinase C (PKC) in intracellular mechanisms of tolerance to morphine analgesia. In the present experiments, we examined (1) the cellular distribution of a PKC isoform (PKCγ) in the spinal cord dorsal horn of rats associated with morphine tolerance by utilizing an immunocytochemical method and (2) the effects of the N-methyl-d-aspartate receptor antagonist MK-801 on tolerance-associated PKCγ changes. In association with the development of tolerance to morphine analgesia induced by once daily intrathecal administration of 10 μg morphine for eight days, PKCγ immunoreactivity was clearly increased in the spinal cord dorsal horn of these same rats. Within the spinal cord dorsal horn of morphine tolerant rats, there were significantly more PKCγ immunostained neurons in laminae I–II than in laminae III–IV and V–VI. Such PKCγ immunostaining was observed primarily in neuronal somata indicating a postsynaptic site of PKCγ increases. Moreover, both the development of morphine tolerance and the increase in PKCγ immunoreactivity were prevented by co-administration of morphine with 10 nmol MK-801 between Day 2 and Day 7 of the eight day treatment schedule. In contrast, PKCγ immunoreactivity was not increased in rats receiving a single i.t. administration of 10 μg morphine on Day 8, nor did repeated treatment with 10 nmol MK-801 alone change baseline levels of PKCγ immunoreactivity. These results provide further evidence for the involvement of PKC in NMDA receptor-mediated mechanisms of morphine tolerance.
Elsevier
以上显示的是最相近的搜索结果。 查看全部搜索结果